Literature DB >> 19949110

Altered CD8(+) T cell immunodominance after vaccinia virus infection and the naive repertoire in inbred and F(1) mice.

Inge E A Flesch1, Wai-Ping Woo, Yang Wang, Vijay Panchanathan, Yik-Chun Wong, Nicole L La Gruta, Tania Cukalac, David C Tscharke.   

Abstract

Previous studies of CD8(+) T cell immunodominance after primary virus infection of F(1) mice compared with their inbred parents have generally concluded that no dramatic changes occur. In this study, we revisit this issue using vaccinia virus (VACV), which has a large genome, a recently defined immunodominance hierarchy in mice, and is a candidate vector for vaccines. We found that immunogenicity of VACV peptides defined using inbred mice was highly variable in F(1) progeny: some peptides were equally immunogenic in F(1) and inbred, whereas others elicited responses that were reduced by >90% in F(1) mice. Furthermore, the dominance of a peptide in the relevant inbred parent did not predict whether it would be poorly immunogenic in F(1) mice. This result held using F(1) hybrids of MHC-congenic mice, suggesting that MHC differences alone were responsible. It was also extended to foreign epitopes expressed by an rVACV vaccine. F(1) mice were less able to mount responses to the poorly immunogenic peptides when used as a sole immunogen, ruling out immunodomination. In addition, conserved TCR Vbeta usage between inbred and F(1) mice did not always correlate with strong responses in F(1) mice. However, direct estimation of naive precursor numbers showed that these were reduced in F(1) compared with inbred mice for specificities that were poorly immunogenic in the hybrids. These data have implications for our understanding of the extent to which MHC diversity alters the range of epitopes that are immunogenic in outbred populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949110      PMCID: PMC2845786          DOI: 10.4049/jimmunol.0900999

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

Review 1.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

2.  Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial.

Authors:  Richard N Greenberg; Jeffrey S Kennedy; David J Clanton; Elizabeth A Plummer; Lynda Hague; John Cruz; Francis A Ennis; William C Blackwelder; Robert J Hopkins
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

3.  MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL.

Authors:  D H Busch; E G Pamer
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

4.  The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant.

Authors:  M E Wallace; R Keating; W R Heath; F R Carbone
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

Authors:  Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

6.  Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Authors:  Jonathan D Silk; Ian F Hermans; Uzi Gileadi; Tsung Wen Chong; Dawn Shepherd; Mariolina Salio; Bini Mathew; Richard R Schmidt; Sarah Jane Lunt; Kaye J Williams; Ian J Stratford; Adrian L Harris; Vincenzo Cerundolo
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

7.  CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.

Authors:  Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

8.  The composition of a primary T cell response is largely determined by the timing of recruitment of individual T cell clones.

Authors:  P Bousso; J P Levraud; P Kourilsky; J P Abastado
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

9.  Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines.

Authors:  David C Tscharke; Gunasegaran Karupiah; Jie Zhou; Tara Palmore; Kari R Irvine; S M Mansour Haeryfar; Shanicka Williams; John Sidney; Alessandro Sette; Jack R Bennink; Jonathan W Yewdell
Journal:  J Exp Med       Date:  2004-12-28       Impact factor: 14.307

Review 10.  Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

Authors:  Ingo Drexler; Caroline Staib; Gerd Sutter
Journal:  Curr Opin Biotechnol       Date:  2004-12       Impact factor: 9.740

View more
  25 in total

1.  Loss in CD4 T-cell responses to multiple epitopes in influenza due to expression of one additional MHC class II molecule in the host.

Authors:  Jennifer L Nayak; Andrea J Sant
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

Review 2.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

Review 3.  Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Authors:  Pavlo Gilchuk; Timothy M Hill; John T Wilson; Sebastian Joyce
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

4.  Ecological analysis of antigen-specific CTL repertoires defines the relationship between naive and immune T-cell populations.

Authors:  Paul G Thomas; Andreas Handel; Peter C Doherty; Nicole L La Gruta
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

5.  Discovering naturally processed antigenic determinants that confer protective T cell immunity.

Authors:  Pavlo Gilchuk; Charles T Spencer; Stephanie B Conant; Timothy Hill; Jennifer J Gray; Xinnan Niu; Mu Zheng; John J Erickson; Kelli L Boyd; K Jill McAfee; Carla Oseroff; Sine R Hadrup; Jack R Bennink; William Hildebrand; Kathryn M Edwards; James E Crowe; John V Williams; Søren Buus; Alessandro Sette; Ton N M Schumacher; Andrew J Link; Sebastian Joyce
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

6.  Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection.

Authors:  Christopher P Loo; Nicholas A Nelson; Ryan S Lane; Jamie L Booth; Sofia C Loprinzi Hardin; Archana Thomas; Mark K Slifka; Jeffrey C Nolz; Amanda W Lund
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

7.  Mycobacterium tuberculosis directs immunofocusing of CD8+ T cell responses despite vaccination.

Authors:  Joshua S Woodworth; Daniel Shin; Mattijs Volman; Cláudio Nunes-Alves; Sarah M Fortune; Samuel M Behar
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

8.  Anatomically restricted synergistic antiviral activities of innate and adaptive immune cells in the skin.

Authors:  Heather D Hickman; Glennys V Reynoso; Barbara F Ngudiankama; Erica J Rubin; Javier G Magadán; Stephanie S Cush; James Gibbs; Barbara Molon; Vincenzo Bronte; Jack R Bennink; Jonathan W Yewdell
Journal:  Cell Host Microbe       Date:  2013-02-13       Impact factor: 21.023

9.  Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope.

Authors:  Tracy J Ruckwardt; Cindy Luongo; Allison M W Malloy; Jie Liu; Man Chen; Peter L Collins; Barney S Graham
Journal:  J Immunol       Date:  2010-09-10       Impact factor: 5.422

10.  A novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.

Authors:  Sojung Kim; Amelia K Pinto; Nancy B Myers; Oriana Hawkins; Krysten Doll; Saghar Kaabinejadian; Jason Netland; Michael J Bevan; Jon A Weidanz; William H Hildebrand; Michael S Diamond; Ted H Hansen
Journal:  Eur J Immunol       Date:  2014-05-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.